| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.932.585.462 $ | +548.043.362 $ | +61,8 % | 10 | 1.288.718.212 $ | +461.619.479 $ | +61,9 % | 7 | 1.102.918.482 $ | +233.967.886 $ | +56,1 % | 8 | ||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 714.882.829 $ | +73.806.960 $ | +11,5 % | 1 | 641.075.869 $ | +303.636.226 $ | +90,0 % | 1 | 337.439.643 $ | -31.425.288 $ | -8,5 % | 1 |
| Erasca, Inc. | ERAS | → 0 | Neutral | 265.073.898 $ | +198.645.549 $ | +299,0 % | 1 | ||||||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 203.480.393 $ | +77.741.540 $ | +61,8 % | 1 | 125.738.853 $ | +45.964.583 $ | +57,6 % | 1 | 79.774.270 $ | +33.270.392 $ | +71,5 % | 1 |
| Metsera, Inc. | → 0 | 196.272.142 $ | +89.565.808 $ | +83,9 % | 1 | ||||||||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 185.893.997 $ | +65.158.721 $ | +54,0 % | 1 | 120.735.276 $ | +75.727.168 $ | +168,3 % | 1 | ||||
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 87.638.463 $ | -1.172.278 $ | -1,3 % | 1 | 88.810.741 $ | -65.046.750 $ | -42,3 % | 1 | 153.857.491 $ | +35.421.844 $ | +29,9 % | 1 |
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 130.331.383 $ | +21.658.275 $ | +19,9 % | 1 | 108.673.108 $ | +26.714.071 $ | +32,6 % | 1 | 81.959.037 $ | +5.887.862 $ | +7,7 % | 1 | |
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 75.945.788 $ | -44.884.116 $ | -37,1 % | 1 | 120.829.904 $ | +37.041.044 $ | +44,2 % | 1 | 83.788.860 $ | +29.508.588 $ | +54,4 % | 1 |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 99.025.600 $ | +57.815.600 $ | +140,3 % | 1 | ||||||||
| Damora Therapeutics, Inc. | GLTO | → 0 | 93.333.111 $ | +93.333.111 $ | 1 | ||||||||||
| Cidara Therapeutics, Inc. | → 0 | 90.664.419 $ | +59.534.443 $ | +191,2 % | 1 | ||||||||||
| Savara Inc | SVRA | → 0 | Stark | 82.854.461 $ | +37.583.137 $ | +83,0 % | 1 | ||||||||
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Neutral | 79.162.620 $ | +12.204.237 $ | +18,2 % | 1 | ||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 76.980.000 $ | +5.940.000 $ | +8,4 % | 1 | ||||||||
| 1.932.585.462 $ | +548.043.362 $ | +61,8 % | 10 | 1.288.718.212 $ | +461.619.479 $ | +61,9 % | 7 | 1.102.918.482 $ | +233.967.886 $ | +56,1 % | 8 | ||||